LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics has successfully maintained a live vaccine's viability for 24 hours at room temperature using its oil suspension technology. This breakthrough ...
Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics (NASDAQ: SMMT).
Zacks.com on MSN7d
Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength?Stoke Therapeutics, Inc. (STOK) shares soared 9.4% in the last ... So, make sure to keep an eye on STOK going forward to see if this recent jump can turn into more strength down the road. The stock ...
Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...
Shares of Axsome Therapeutics (NASDAQ: AXSM) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...
Joel Beatty; Analyst; Robert W. Baird & Co. Incorporated ...
February 10, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both ...
H.C. Wainwright downgraded Pliant Therapeutics (PLRX) to Neutral from Buy without a price target after the company voluntarily paused ...
Stoke Therapeutics, Inc. (STOK ... So, make sure to keep an eye on STOK going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks ...
Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback